ATLANTA--(BUSINESS WIRE)--Parker H. “Pete” Petit, former Chairman and CEO of MiMedx Group, Inc. (OTC PINK:MDXG) and CEO of The Petit Group wishes to inform interested parties relative to today’s press releases from the Department of Justice, Securities and Exchange Commission, MiMedx Group and his law firm, Freshfields, Bruckhaus Deringer US LLP that his personal website, www.petepetit.com, has additional information on this overall situation.
Freshfields Bruckhaus Deringer LLP (‘Freshfields’) Partner Eric B. Bruce responded today to charges announced by the DOJ and SEC against his client, Parker H. “Pete” Petit, the former CEO of MiMedx (OTC PINK: MDXG), as follows: “For 37 years, Pete Petit has conducted himself with the highest degree of integrity and professionalism as the Chairman and/or CEO of six different publicly-traded companies. To be clear: Pete did nothing wrong at MiMedx. Instead, he did everything right – eventually growing the company into the fifth fastest-growing public company in America, according to Fortune magazine, while delivering significant shareholder value and critical medical products to many needy patients.”
If you go to that website, please click on “PROFESSIONAL” and then click on tabs under “MiMedx Group.” The website has a substantial amount of information on subjects, such as the MiMedx History, the MiMedx Investigation, Illegal Short Selling, the Sally Yates Doctrine, Vascular Solutions’ DOJ trial, and the MiMedx proxy contest.